78 related articles for article (PubMed ID: 29698172)
1. Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia.
Castro JC; Daza AM; Misas JD
Value Health Reg Issues; 2015 Dec; 8():56-61. PubMed ID: 29698172
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis.
Migliore A; Integlia D; Pompilio G; Di Giuseppe F; Aru C; Brown T
Clinicoecon Outcomes Res; 2019; 11():453-464. PubMed ID: 31413608
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.
Torrance GW; Raynauld JP; Walker V; Goldsmith CH; Bellamy N; Band PA; Schultz M; Tugwell P;
Osteoarthritis Cartilage; 2002 Jul; 10(7):518-27. PubMed ID: 12127831
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
[TBL] [Abstract][Full Text] [Related]
5. Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis.
Waddell DD; Bricker DC
J Manag Care Pharm; 2007 Mar; 13(2):113-121. PubMed ID: 17330972
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized trial comparing the efficacy of single 6-ml injection of hylan G-F 20 and hyaluronic acid for primary knee arthritis: a preliminary study.
Khanasuk Y; Dechmaneenin T; Tanavalee A
J Med Assoc Thai; 2012 Oct; 95 Suppl 10():S92-7. PubMed ID: 23451445
[TBL] [Abstract][Full Text] [Related]
7. Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis.
Migliore A; Giovannangeli F; Granata M; Laganà B
Clin Med Insights Arthritis Musculoskelet Disord; 2010 Sep; 3():55-68. PubMed ID: 21151854
[TBL] [Abstract][Full Text] [Related]
8. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Impact of a Novel Smartphone Application Compared With Standard Follow-Up on Mobility of Patients With Knee Osteoarthritis Following Treatment With Hylan G-F 20: A Randomized Controlled Trial.
Skrepnik N; Spitzer A; Altman R; Hoekstra J; Stewart J; Toselli R
JMIR Mhealth Uhealth; 2017 May; 5(5):e64. PubMed ID: 28487266
[TBL] [Abstract][Full Text] [Related]
10. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
[TBL] [Abstract][Full Text] [Related]
11. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
[TBL] [Abstract][Full Text] [Related]
12. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
Waddell DD; Cefalu CA; Bricker DC
Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.
Raynauld JP; Goldsmith CH; Bellamy N; Torrance GW; Polisson R; Belovich D; Pericak D; Tugwell P
Osteoarthritis Cartilage; 2005 Feb; 13(2):111-9. PubMed ID: 15694572
[TBL] [Abstract][Full Text] [Related]
14. Delayed Total Knee Replacement with Hylan G-F 20.
Waddell DD; Joseph B
J Knee Surg; 2016 Feb; 29(2):159-68. PubMed ID: 25349988
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.
Bellamy N; Bell MJ; Goldsmith CH; Pericak D; Walker V; Raynauld JP; Torrance GW; Tugwell P; Polisson R
Osteoarthritis Cartilage; 2005 Feb; 13(2):104-10. PubMed ID: 15694571
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Comparative Analysis of Opioid Use and Intra-Articular Corticosteroid Injections Before and After Initial Treatment of Knee Osteoarthritis with Hylan G-F 20.
Khangulov V; Zhang X; Munson SH; Peyerl F; Rey F
Open Access Rheumatol; 2020; 12():79-85. PubMed ID: 32581606
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Efficacy and Tolerability of Hylan G-F 20 in Patients with and without Effusions at the Time of Initial Injection.
Waddell BS; Waddell WH; Waddell DD
J Knee Surg; 2015 Jun; 28(3):213-22. PubMed ID: 24807194
[TBL] [Abstract][Full Text] [Related]
19. Intra-Articular, Single-Shot Hylan G-F 20 Hyaluronic Acid Injection Compared with Corticosteroid in Knee Osteoarthritis: A Double-Blind, Randomized Controlled Trial.
Tammachote N; Kanitnate S; Yakumpor T; Panichkul P
J Bone Joint Surg Am; 2016 Jun; 98(11):885-92. PubMed ID: 27252432
[TBL] [Abstract][Full Text] [Related]
20. Patients with Rheumatoid Arthritis have Similar Excellent Outcomes after Total Knee Replacement Compared with Patients with Osteoarthritis.
Goodman SM; Johnson B; Zhang M; Huang WT; Zhu R; Figgie M; Alexiades M; Mandl LA
J Rheumatol; 2016 Jan; 43(1):46-53. PubMed ID: 26628605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
